N-acetylcysteine Inhibit Biofilms Produced by Pseudomonas Aeruginosa

Overview

Journal BMC Microbiol

Publisher Biomed Central

Specialty Microbiology

Date 2010 May 14

PMID 20462423

Citations 90

Authors

Tiemei Zhao

Youning Liu

Affiliations

Soon will be listed here.

Abstract

Background: Pseudomonas aeruginosa is a common pathogen in chronic respiratory tract infections. It typically makes a biofilm, which makes treatment of these infections difficult. In this study, we investigated the inhibitory effects of N-acetylcysteine (NAC) on biofilms produced by P. aeruginosa.

Results: We found that minimum inhibitory concentrations (MICs) of NAC for most isolates of P. aeruginosa were 10 to 40 mg/ml, the combination of NAC and ciprofloxacin (CIP) demonstrated either synergy (50%) or no interaction (50%) against the P. aeruginosa strains. NAC at 0.5 mg/ml could detach mature P. aeruginosa biofilms. Disruption was proportional to NAC concentrations, and biofilms were completely disrupted at 10 mg/ml NAC. Analysis using COMSTAT software also showed that PAO1 biofilm biomass decreased and its heterogeneity increased as NAC concentration increased. NAC and ciprofloxacin showed significant killing of P. aeruginosa in biofilms at 2.5 mg/ml and > 2 MIC, respectively (p < 0.01). NAC-ciprofloxacin combinations consistently decreased viable biofilm-associated bacteria relative to the control; this combination was synergistic at NAC of 0.5 mg/ml and CIP at 1/2MIC (p < 0.01). Extracellular polysaccharides (EPS) production by P. aeruginosa also decreased by 27.64% and 44.59% at NAC concentrations of 0.5 mg/ml and 1 mg/ml.

Conclusions: NAC has anti-bacterial properties against P. aeruginosa and may detach P. aeruginosa biofilms. Use of NAC may be a new strategy for the treatment of biofilm-associated chronic respiratory infections due to P. aeruginosa, although it would be appropriate to conduct clinical studies to confirm this.

Citing Articles

Lavandula dentata leaves as potential natural antibiofilm agents against Pseudomonas aeruginosa.

Aboulwafa M, Mostafa N, Youssef F, Eldahshan O, Singab A Sci Rep. 2025; 15(1):8540.

PMID: 40074746 PMC: 11903892. DOI: 10.1038/s41598-025-88824-5.

Synergistic action of mucoactive drugs and phages against and .

Sui B, Li X, Li N, Tao Y, Wang L, Xu Y Microbiol Spectr. 2025; 13(3):e0160124.

PMID: 39912676 PMC: 11878038. DOI: 10.1128/spectrum.01601-24.

Antibiotics-free compounds for managing carbapenem-resistant bacteria; a narrative review.

Shariati A, Kashi M, Chegini Z, Hosseini S Front Pharmacol. 2024; 15:1467086.

PMID: 39355778 PMC: 11442292. DOI: 10.3389/fphar.2024.1467086.

Liposomal Drug Delivery against Using Furazolidone and N-Acetyl Cysteine in Augmented Therapy.

Alam M, Paget T, Yussuf Moosa N, Alghurairy H, Elkordy A Pharmaceutics. 2024; 16(9).

PMID: 39339161 PMC: 11435436. DOI: 10.3390/pharmaceutics16091123.

Sinus Irrigation with N-Acetylcysteine after Endoscopic Sinus Surgery for Chronic Rhinosinusitis: A Preliminary Report of a Single-Blind Randomized Controlled Trial.

Wee J, Park J, Park M, Choi Y, Jung H Diagnostics (Basel). 2024; 14(15).

PMID: 39125554 PMC: 11311464. DOI: 10.3390/diagnostics14151678.

References

Roberts D, Cole P . N-acetylcysteine potentiates the anti-pseudomonas activity of carbenicillin in vitro. J Infect. 1981; 3(4):353-9. DOI: 10.1016/s0163-4453(81)91958-7. View

Ho P, Chan K, Ip M, Lam W, Ho C, Yuen K . The effect of Pseudomonas aeruginosa infection on clinical parameters in steady-state bronchiectasis. Chest. 1999; 114(6):1594-8. DOI: 10.1378/chest.114.6.1594. View

Yanagihara K, Tomono K, Sawai T, Kuroki M, Kaneko Y, Ohno H . Combination therapy for chronic Pseudomonas aeruginosa respiratory infection associated with biofilm formation. J Antimicrob Chemother. 2000; 46(1):69-72. DOI: 10.1093/jac/46.1.69. View

Evans S, Turner S, Bosch B, HARDY C, Woodhead M . Lung function in bronchiectasis: the influence of Pseudomonas aeruginosa. Eur Respir J. 1996; 9(8):1601-4. DOI: 10.1183/09031936.96.09081601. View

Dall L, Herndon B . Quantitative assay of glycocalyx produced by viridans group streptococci that cause endocarditis. J Clin Microbiol. 1989; 27(9):2039-41. PMC: 267733. DOI: 10.1128/jcm.27.9.2039-2041.1989. View

Perez-Giraldo C, Moran F, Hurtado C, Blanco M, Gomez-Garcia A . Influence of N-acetylcysteine on the formation of biofilm by Staphylococcus epidermidis. J Antimicrob Chemother. 1997; 39(5):643-6. DOI: 10.1093/jac/39.5.643. View

Stafanger G, Koch C . N-acetylcysteine in cystic fibrosis and Pseudomonas aeruginosa infection: clinical score, spirometry and ciliary motility. Eur Respir J. 1989; 2(3):234-7. View

Koch C, Hoiby N . Pathogenesis of cystic fibrosis. Lancet. 1993; 341(8852):1065-9. DOI: 10.1016/0140-6736(93)92422-p. View

Mah T, OToole G . Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol. 2001; 9(1):34-9. DOI: 10.1016/s0966-842x(00)01913-2. View

10.

Lin S, Kuo P, Hsueh P, Yang P, Kuo S . Sputum bacteriology in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease in Taiwan with an emphasis on Klebsiella pneumoniae and Pseudomonas aeruginosa. Respirology. 2007; 12(1):81-7. DOI: 10.1111/j.1440-1843.2006.00999.x. View

11.

Gomez-Flores R, Gupta S, Tamez-Guerra R, MEHTA R . Determination of MICs for Mycobacterium avium-M. intracellulare complex in liquid medium by a colorimetric method. J Clin Microbiol. 1995; 33(7):1842-6. PMC: 228282. DOI: 10.1128/jcm.33.7.1842-1846.1995. View

12.

El-Feky M, El-Rehewy M, Hassan M, Abolella H, Abd El-Baky R, Gad G . Effect of ciprofloxacin and N-acetylcysteine on bacterial adherence and biofilm formation on ureteral stent surfaces. Pol J Microbiol. 2009; 58(3):261-7. View

13.

Rand K, Houck H, Brown P, Bennett D . Reproducibility of the microdilution checkerboard method for antibiotic synergy. Antimicrob Agents Chemother. 1993; 37(3):613-5. PMC: 187717. DOI: 10.1128/AAC.37.3.613. View

14.

Stepanovic S, Vukovic D, Hola V, Di Bonaventura G, Djukic S, Cirkovic I . Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci. APMIS. 2007; 115(8):891-9. DOI: 10.1111/j.1600-0463.2007.apm_630.x. View

15.

Schwandt L, van Weissenbruch R, Stokroos I, van der Mei H, Busscher H, Albers F . Prevention of biofilm formation by dairy products and N-acetylcysteine on voice prostheses in an artificial throat. Acta Otolaryngol. 2004; 124(6):726-31. DOI: 10.1080/00016480410022516. View

16.

Marchese A, Bozzolasco M, Gualco L, Debbia E, Schito G, Schito A . Effect of fosfomycin alone and in combination with N-acetylcysteine on E. coli biofilms. Int J Antimicrob Agents. 2003; 22 Suppl 2:95-100. DOI: 10.1016/s0924-8579(03)00232-2. View

17.

Parry M, Neu H . Effect of N-acetylcysteine on antibiotic activity and bacterial growth in vitro. J Clin Microbiol. 1977; 5(1):58-61. PMC: 274532. DOI: 10.1128/jcm.5.1.58-61.1977. View

18.

Angrill J, Agusti C, De Celis R, Rano A, Gonzalez J, Sole T . Bacterial colonisation in patients with bronchiectasis: microbiological pattern and risk factors. Thorax. 2002; 57(1):15-9. PMC: 1746176. DOI: 10.1136/thorax.57.1.15. View

19.

Cai S, Zhang J, Qian G . [Correlation of endotracheal tube biofilm and recurrent ventilator-associated pneumonia with Pseudomonas aeruginosa]. Zhonghua Jie He He Hu Xi Za Zhi. 2002; 24(6):339-41. View

20.

Lode H, Allewelt M, Balk S, de Roux A, Mauch H, Niederman M . A prediction model for bacterial etiology in acute exacerbations of COPD. Infection. 2007; 35(3):143-9. DOI: 10.1007/s15010-007-6078-z. View